CHARACTERISTICS AND OUTCOMES FOR STATIN-INTOLERANT WOMEN RECEIVING BEMPEDOIC ACID IN THE CLEAR OUTCOMES TRIAL

被引：0
|
作者：
Cho, Leslie [1 ]
Plutzky, Jorge [1 ]
Brennan, Danielle [1 ]
Louie, Michael [1 ]
Lei, Lei [1 ]
Robinson, Paula [1 ]
Powell, Heather [1 ]
Nicholls, Stephen J. [1 ]
Lincoff, A. Michael [1 ]
Nissen, Steven E. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1213-224
引用
收藏
页码：1751 / 1751
页数：1
相关论文
共 50 条
  • [21] Statin Intolerance, Bempedoic Acid, and Cardiovascular Outcomes
    Spacek, Lance
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (26): : 2488 - 2488
  • [22] CLEARING THE ROLE OF BEMPEDOIC ACID FOR DYSLIPIDEMIA IN STATIN-INTOLERANT PATIENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ternes, Caique M. P.
    Pasqualotto, Eric
    Wippel, Catherine Wegner
    Fernandes, Amanda
    Rivera, Andre
    Braga, Marcelo
    Costa Fernandes Filho, Gilson M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2022 - 2022
  • [23] Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
    Nicholls, Stephen J.
    Lincoff, A. Michael
    Bays, Harold E.
    Cho, Leslie
    Grobbee, Diederick E.
    Kastelein, John J. P.
    Libby, Peter
    Moriarty, Patrick M.
    Plutzky, Jorge
    Ray, Kausik K.
    Thompson, Paul D.
    Sasiela, William
    Mason, Denise
    McCluskey, Jaclyn
    Davey, Deborah
    Wolski, Kathy
    Nissen, Steven E.
    AMERICAN HEART JOURNAL, 2021, 235 : 104 - 112
  • [24] Statin Intolerance, Bempedoic Acid, and Cardiovascular Outcomes Reply
    Nissen, Steven E.
    Nicholls, Stephen J.
    Lincoff, A. Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (26): : 2489 - 2490
  • [25] PCSK9 inhibitor, ezetimibe, and bempedoic acid: Evidence-based therapies for statin-intolerant patients
    Gunta, Satya Preetham
    O'Keefe, James H.
    O'Keefe, Evan L.
    Lavie, Carl J.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 79 : 12 - 18
  • [26] In higher-risk, statin-intolerant adults with diabetes, bempedoic acid reduced MACE at a median 3 y
    Kelsey, Michelle
    Newby, L. Kristin
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (04) : JC39 - JC39
  • [27] Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
    Ballantyne, Christie M.
    Banach, Maciej
    Mancini, G. B. John
    Lepor, Norman E.
    Hanselman, Jeffrey C.
    Zhao, Xin
    Leiter, Lawrence A.
    ATHEROSCLEROSIS, 2018, 277 : 195 - 203
  • [28] IMPACT OF BEMPEDOIC ACID ON CARDIOVASCULAR EVENTS IN HIGH RISK PATIENTS WITH STATIN INTOLERANCE: THE CLEAR OUTCOMES STUDY
    Nicholls, S.
    ATHEROSCLEROSIS, 2023, 379
  • [29] Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis
    Hamayal, Muhammad
    Shahid, Warda
    Akhtar, Chaudhary Humayun
    Shekiba, Fnu
    Iftikhar, Iqra
    Tahir, Muhammad Danyal
    Awwab, Muhammad
    Hussain, Saima
    Naeem, Saman
    Hafeez, Momina
    FUTURE CARDIOLOGY, 2024, 20 (11-12) : 639 - 650
  • [30] BEMPEDOIC ACID AND CARDIOVASCULAR DISEASE OUTCOMES IN PATIENTS WITH OBESITY: A CLEAR OUTCOMES SUBSET ANALYSIS
    Bays, Harold E.
    Bloedon, Leanne
    Brennan, Danielle
    Lei, Lei
    Lincoff, A. Michael
    Nicholls, Stephen
    Plutzky, Jorge
    Powell, Heather A.
    Nissen, Steve E.
    ATHEROSCLEROSIS, 2024, 395
12345